RENOVARO INC. - COMMON STOCK

UPDATE - Renovaro Inc. Announces Expedited Trial for 2025 Lawsuit to Enforce Binding Merger Agreement with Predictive Oncology

22 May 2025 12:12:39 By Nasdaq GlobeNewswire

Renovaro Inc. Announces Expedited Trail for 2025 Lawsuit to Enforce Binding Merger Agreement with Predictive Oncology

22 May 2025 08:05:00 By Nasdaq GlobeNewswire

Renovaro Launches Augusta, an AI-Powered Precision Neurology Platform

14 May 2025 06:15:00 By Nasdaq GlobeNewswire

Renovaro and Amsterdam University Medical Center Announce Exclusive Collaboration to Advance Blood Platelet RNA Diagnostics

13 May 2025 06:15:00 By Nasdaq GlobeNewswire

Renovaro Secures High-Powered Computing from Nebul Through a Partnership to Accelerate Next-Generation Biomarker Discovery and Diagnostic Programs

22 Apr 2025 06:19:59 By Nasdaq GlobeNewswire

Renovaro and BioSymetrics Close Merger to Accelerate AI-Driven Biomarker Discovery and Precision Medicine

09 Apr 2025 06:25:00 By Nasdaq GlobeNewswire

Renovaro Provides Update to Definitive Agreement with Predictive Oncology

04 Apr 2025 06:40:00 By Nasdaq GlobeNewswire

Renovaro Completes First Milestone Payment to Finalize Definitive Agreement with Predictive Oncology

03 Mar 2025 06:15:00 By Nasdaq GlobeNewswire

Renovaro and BioSymetrics Announce Definitive Merger Agreement to Advance AI-Driven Biomarker Discovery and Precision Medicine

26 Feb 2025 10:25:00 By Nasdaq GlobeNewswire

Renovaro Announces $15 million in Equity Committed

26 Feb 2025 06:15:00 By Nasdaq GlobeNewswire

Renovaro Appoints Nathen Fuentes as Chief Financial Officer

07 Jan 2025 06:15:00 By Nasdaq GlobeNewswire

Renovaro Issues Shareholder Letter and Provides Corporate Update

07 Jan 2025 06:15:00 By Nasdaq GlobeNewswire

Renovaro to Acquire Predictive Oncology in All-Stock Transaction

06 Jan 2025 06:15:00 By Nasdaq GlobeNewswire

Renovaro Inc. Appoints Maurice van Tilburg to Lead GEDi Cube BV

30 Dec 2024 06:00:05 By Nasdaq GlobeNewswire

RenovaroCube Receives Approval of Lumina Project by the Eurostars Funding Program

23 Dec 2024 06:00:00 By Nasdaq GlobeNewswire

Renovaro Regains Compliance with NASDAQ Listing Requirement

20 Dec 2024 12:40:00 By Nasdaq GlobeNewswire

Renovaro Enters into a Strategic Collaboration with Nebul to Advance a Paradigm Shift for Early Disease Detection

20 Dec 2024 06:00:00 By Nasdaq GlobeNewswire

Renovaro Issues Shareholder Letter and Provides Corporate Update

04 Nov 2024 05:31:00 By Nasdaq GlobeNewswire

RenovaroCube Presents Novel Insights on Non-Invasive Cancer Diagnostics Using Oxford Nanopore Sequencing

17 Oct 2024 06:15:17 By Nasdaq GlobeNewswire

Renovaro Announces Strategic Restructuring and Leadership Transition

16 Oct 2024 06:28:06 By Nasdaq GlobeNewswire